☆ 4.4 Article

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Ophthalmology

Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders

Richard F. Spaide et al.

Summary: Central serous chorioretinopathy (CSC) is characterized by fluid leakage at the level of the retinal pigment epithelium, leading to macular detachment. Recent evaluations have shown that eyes with CSC have similar choroidal vascular abnormalities as eyes following occlusion of the vortex veins or carotid cavernous sinus fistulas. Abnormal venous outflow from the choroid appears to be a key factor in the pathophysiology of CSC.

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

Add to Collection

Article Ophthalmology

Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial

Thomas J. van Rijssen et al.

Summary: This study compared the efficacy and safety of half-dose photodynamic therapy and eplerenone therapy for treating chronic central serous chorioretinopathy. The results showed that half-dose PDT was superior to eplerenone treatment in terms of short-term safety and efficacy outcomes.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2022)

Add to Collection

Review Ophthalmology

Exploring the choroidal vascular labyrinth and its molecular and structural roles in health and disease

J. Brinks et al.

Summary: The choroid plays a crucial role in maintaining ocular homeostasis and is involved in various chorioretinal diseases. Recent advances in single-cell RNA sequencing have provided valuable insights into the characteristics of choroidal endothelial cells (CECs).

PROGRESS IN RETINAL AND EYE RESEARCH (2022)

Add to Collection

Article Ophthalmology

Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients

Helena M. A. Feenstra et al.

Summary: This study compared the efficacy and safety of crossover treatment between half-dose photodynamic therapy (PDT) and eplerenone treatment in patients with chronic central serous chorioretinopathy (cCSC). The results showed that half-dose PDT was more effective in resolving subretinal fluid (SRF) and improving foveal sensitivity compared to eplerenone treatment after the failure of primary treatment.

OPHTHALMOLOGY RETINA (2022)

Add to Collection

Article Ophthalmology

Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser

Thomas J. van Rijssen et al.

Summary: Following the completion of the PLACE trial, cCSC patients who were successfully treated with half-dose PDT were less likely to experience recurrences of SRF compared to those treated with HSML. However, there were no differences in functional outcomes between the two treatment groups.

ACTA OPHTHALMOLOGICA (2021)

Add to Collection

Review Ophthalmology

Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula

Elon H. C. van Dijk et al.

Summary: This manuscript categorizes a variety of ocular diseases that may cause subretinal fluid accumulation in the macula, including neovascular diseases, inflammatory diseases, and ocular tumors. Distinguishing between these diseases and CSC can be challenging, but obtaining the correct diagnosis is crucial for immediate therapeutic and prognostic consequences.

PROGRESS IN RETINAL AND EYE RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Andrew Lotery et al.

LANCET (2020)

Add to Collection

Article Ophthalmology

CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Danial Mohabati et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)

Add to Collection

Article Ophthalmology

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY

Danial Mohabati et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)

Add to Collection

Article Ophthalmology

Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial

Thomas J. van Rijssen et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach

Elon H. C. van Dijk et al.

OPHTHALMOLOGY AND THERAPY (2020)

Add to Collection

Article Ophthalmology

FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY

Elon H. C. van Dijk et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)

Add to Collection

Article Ophthalmology

Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients

M. Giray Ersoz et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2019)

Add to Collection

Review Ophthalmology

Pachychoroid disease

Chui Ming Gemmy Cheung et al.

EYE (2019)

Add to Collection

Review Ophthalmology

Central serous chorioretinopathy: Towards an evidence-based treatment guideline

Thomas J. van Rijssen et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2019)

Add to Collection

Article Ophthalmology

Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy

Sarah Mrejen et al.

OPHTHALMOLOGY (2019)

Add to Collection

Article Ophthalmology

GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY

Danial Mohabati et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)

Add to Collection

Article Ophthalmology

Elevated Steroid Hormone Levels in Active Chronic Central Serous Chorioretinopathy

Rosa L. Schellevis et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)

Add to Collection

Article Ophthalmology

Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial

Elon H. C. van Dijk et al.

OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy

Danial Mohabati et al.

CLINICAL OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy

Danial Mohabati et al.

CLINICAL OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

Myrte B. Breukink et al.

CLINICAL OPHTHALMOLOGY (2017)

Add to Collection

Article Ophthalmology

Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis

Alejandra Daruich et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2015)

Add to Collection

Article Ophthalmology

Genomic Copy Number Variations of the Complement Component C4B Gene Are Associated With Chronic Central Serous Chorioretinopathy

Myrte B. Breukink et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)

Add to Collection

Article Ophthalmology

ONE-YEAR CHOROIDAL THICKNESS RESULTS AFTER PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY

Ichiro Maruko et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)

Add to Collection

Article Ophthalmology

Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy

RH Loo et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.